Deerfield Management’s Windtree Therapeutics Inc WINT Stock Holding History

Deerfield Management’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-609,857	Closed	-$2.56M	–	141
2015 Q3	$2.56M	Buy	609,857 +348,450	+133%	+$2.31M	0.1%	109
2015 Q2	$2.49M	Hold	261,407	–	–	0.08%	105
2015 Q1	$4.36M	Hold	261,407	–	–	0.14%	89
2014 Q4	$4.25M	Hold	261,407	–	–	0.15%	86
2014 Q3	$6.73M	Hold	261,407	–	–	0.25%	81
2014 Q2	$6.51M	Hold	261,407	–	–	0.26%	78
2014 Q1	$7.87M	Hold	261,407	–	–	0.32%	75
2013 Q4	$8.23M	Buy	261,407 +176,550	+208%	+$5.52M	0.43%	62
2013 Q3	$2.33M	Sell	84,857 -10,357	-11%	-$251K	0.11%	95
2013 Q2	$2.03M	Buy	+95,214	New	+$2.35M	0.1%	91

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Deerfield Management's WINT Position: Q4 2015 in Review

Deerfield Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2015, closing a stake of 609,857 shares — an estimated $2.56M sold.

Deerfield Management first reported a position in WINT in Q2 2013 and held it in 10 quarters. The position peaked at $8.23M in Q4 2013. 53 funds tracked by Wall St. Rank hold WINT as of Q4 2015.

Deerfield Management reported no remaining Windtree Therapeutics Inc position as of Q4 2015 after selling out during the quarter.
Deerfield Management sold 609,857 Windtree Therapeutics Inc shares in Q4 2015, an estimated $2.56M.
Deerfield Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 10 quarters.
Deerfield Management's Windtree Therapeutics Inc position peaked at $8.23M in Q4 2013.
53 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2015.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.